Shamir Course for Complex Coronary Interventions

Dr. Ilya Litovchik is a senior interventional cardiologist at Shamir Medical Center, Israel. He graduated from the medical school of Lviv, Ukraine in 1994. After completing his residency in internal medicine and cardiology in Israel, Dr. Litovchik became the IDF's chief cardiologist. Following his military service, he continued to specialize in interventional cardiology. In addition to his training in Israel, Dr. Litovchik attended fellowship programs in Italy and Japan. He has performed thousands of coronary and structural procedures at Shamir Medical Center. Since 2018, he turned to the CTO field which was still underdeveloped in Israel. As part of his work, he initiated the Israeli National CTO Registry. Today, Dr. Litovchik coordinates and leads the CTO activity in Israel and participates and presents at international conferences in Israel and abroad. He also conducts practical workshops and proctoring programs in a variety of fields related to coronary interventions, such as coronary physiology and imaging as well as structural intervention.

Dr Kambis Mashayekhi is Head of the Department of Internal Medicine and Cardiology in Heart Center Lahr in Germany. Dr. Mashayekhi is performing over 350 CTO-PCI’s per year and is an world-renowned CTO and complex PCI specialist. Dr. Mashayekhi is the head of the CTO working group from the German Society of cardiology and the Co-Director of MLCTO and EuroCTO course. He is the new EuroCTO president elect for 2023.

Dr Sunao Nakamura is one of the most experienced interventional cardiologist Japan. He had performed more than 25,000 cases of PCI and 10,000 cases of chronic total occlusion (CTO) which is a biggest numbers in the world. He has a very unique background as a researcher; studying about cellular electro-physiology for 6 years and clinical sciences for 4 years in his younger days. After that he suddenly changed his main field of cardiology; Interventional cardiology with respect of Prof. Shigeru Saito ; who was active in the leadership position in Asia region, Dr. Nakamura worked disseminate PCI in Asia from his age early 30s and experienced living a half of the year in foreign countries. As a result of through these actives over the years, he has built good relations with many doctors who share the same goals all over the world. His motto is that patients around the world should be saved not only we think about the patients who come here to our hospital by sharing each other’s skills and knowledge. He is also fully engaged in the leading edge of clinical activities and researches, and at his New Tokyo Hospital, many clinical and basic studies are conducted every year, and about 30 papers are published annually. Especially in close relation with Professor Antonio Colombo, Italy, our young doctors who received his guidance are active not only as a physician but also as a medical scientist in New Tokyo Hospital. His dream is to make the world's leading heart center capable of medical research from basic to clinical.

Dr Sunao Nakamura is one of the most experienced interventional cardiologist Japan. He had performed more than 25,000 cases of PCI and 10,000 cases of chronic total occlusion (CTO) which is a biggest numbers in the world. He has a very unique background as a researcher; studying about cellular electro-physiology for 6 years and clinical sciences for 4 years in his younger days. After that he suddenly changed his main field of cardiology; Interventional cardiology with respect of Prof. Shigeru Saito ; who was active in the leadership position in Asia region, Dr. Nakamura worked disseminate PCI in Asia from his age early 30s and experienced living a half of the year in foreign countries. As a result of through these actives over the years, he has built good relations with many doctors who share the same goals all over the world. His motto is that patients around the world should be saved not only we think about the patients who come here to our hospital by sharing each other’s skills and knowledge. He is also fully engaged in the leading edge of clinical activities and researches, and at his New Tokyo Hospital, many clinical and basic studies are conducted every year, and about 30 papers are published annually. Especially in close relation with Professor Antonio Colombo, Italy, our young doctors who received his guidance are active not only as a physician but also as a medical scientist in New Tokyo Hospital. His dream is to make the world's leading heart center capable of medical research from basic to clinical.

Dr Sharp qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011, before moving to the University Hospital of Wales, in Cardiff, UK in the summer of 2019, where he is now Honorary Professor of Cardiology. He conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training. He completed the Milan-Imperial Interventional Cardiology Fellowship programme, having spent a year in San Raffaele and Columbus Hospitals, Milan, Italy, under the tutelage of Professor Antonio Colombo. He also spent three years training in interventional cardiology at St Mary’s Hospital and The Hammersmith Hospital (Imperial College Hospitals) in London. Prof Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and leads a large research programme in Wales. He has an international reputation for leading the development of device-based treatments for hypertension (in particular that of renal denervation) and pulmonary embolism, as well as the advancement of intracoronary imaging and physiology.

Dr Justin Davies is founder and CEO of Wondr Medical, inventor of iFR, and clinical academic and consultant interventional cardiologist at the National Heart and Lung Institute, Imperial College London.

A consultant cardiologist at VU University Medical Centre, Amsterdam, The Netherlands. Features in 4 videos on Wondr Medical. Paul Knaapen generally speaks on Chronic Total Occlusion (CTO), Stable Coronary Artery Disease (CAD), CT Coronary Angiography, and Coronary Interventions.

Dr Roberto Garbo is an Interventional Cardiologist in Maria Pia Hospital GVM Care & Research, Turin, Italy. He is a Director of CTO and Complex PCI program, Board member of EuroCTO Club since 2017 and IVUS guided CTO expert in both antegrade and retrograde approach. Dr Garbo is a Director of Turin CTO&CHIp Live course.

Sa’ar Minha MD is a professor of cardiology at Tel-Aviv University, Israel, and the director of interventional cardiology at Shamir Medical Center, Be’er Yaakov in Israel- one of the largest government-owned hospitals in the country. He also serves as the secretary of the interventional cardiology working group under the Israel Heart Society. Prof. Minha earned his MD degree from Tel-Aviv University in Israel and completed an internal medicine residency and cardiology fellowship at Shamir Medical Center. His interventional cardiology fellowship was completed in 2014 at the Washington Hospital Center, affiliated with Georgetown University, Washington DC under Prof. Ron Waksman, Prof. Gus Pichard, and Prof. Lowell Satler. Prof Minha is an active speaker and an invited faculty for major international cardiology conferences and the co-author of over 110 original research publications. His main interests are complex coronary interventions combining physiology and imaging for optimizing results and outcomes, interventions for pulmonary embolism, renal denervation for treating hypertension, and interventions under mechanical circulatory support.

Dr Justin Davies is founder and CEO of Wondr Medical, inventor of iFR, and clinical academic and consultant interventional cardiologist at the National Heart and Lung Institute, Imperial College London.